Unlocking stability: predictors of clinical stability in patients undergoing intermittent levosimendan infusions for advanced heart failure

被引:0
|
作者
Filipa Gerardo, F. [1 ]
Passos, M. [1 ]
Fialho, I. [1 ]
Oliveira Soares, A. [1 ]
Mateus, C. [1 ]
Miranda, I. [1 ]
Lima Lopes, J. [1 ]
Sarmento, M. [1 ]
Roque, D. [1 ]
机构
[1] Hosp Prof Doutor Fernando Fonseca, Amadora, Portugal
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:408 / 408
页数:1
相关论文
共 50 条
  • [31] Monthly levosimendan infusions in the treatment of advanced heart failure: the net clinical benefit beyond simple palliative care
    Fontana, A.
    Vincenzi, A.
    Ciro, A.
    Frattola, A.
    Vigano, E.
    Cagnan, P.
    Santi, A.
    Achilli, F.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S339 - S339
  • [32] Use of Levosimendan in Patients with Advanced Heart Failure: An Update
    Masarone, Daniele
    Kittleson, Michelle M.
    Pollesello, Piero
    Marini, Marco
    Iacoviello, Massimo
    Oliva, Fabrizio
    Caiazzo, Angelo
    Petraio, Andrea
    Pacileo, Giuseppe
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (21)
  • [33] Levosimendan as bridge to transplant in patients with advanced heart failure
    Ponz de Antonio, Ines
    de Juan Baguda, Javier S.
    Rodriguez Chaverri, Adriana
    Garcia-Cosio Carmena, Maria Dolores
    Arribas Ynsaurriaga, Fernando
    Delgado Jimenez, Juan F.
    REVISTA ESPANOLA DE CARDIOLOGIA, 2020, 73 (05): : 422 - 424
  • [34] Patients with advanced heart failure and the effects of Levosimendan : Reply
    Parissis, John T.
    Farmakis, Dimitrios
    Praskevaidis, Loannis
    Bistola, Vassiliki
    Filippatos, Gerasithos
    Krernastinos, Dimitrios T.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (04): : 742 - 743
  • [35] Levosimendan is safe to patients with advanced heart failure and hypotension
    Wang, Min
    Luo, Beibei
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 338 : 153 - 153
  • [36] CLINICAL OUTCOMES AND ADVERSE EVENTS IN CONTEMPORARY PATIENTS WITH ADVANCED HEART FAILURE RECEIVING REPEATED, PLANNED LEVOSIMENDAN INFUSIONS FOR SYMPTOMS CONTROL AND AS A BRIDGE TO HEART TRANSPLANTATION
    Galeotti, G.
    Verde, A.
    Masciocco, G.
    Foti, G.
    Perna, E.
    Ammirati, E.
    Cipriani, M.
    Frigerio, M.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0G) : G28 - G29
  • [37] Advanced echocardiographic assessment in outpatients with advanced heart failure undergoing periodical levosimendan infusion
    Morello, Matteo
    Miglierina, Emilio
    Golino, Michele
    Ceriani, Francesca
    Oliva, Carlo
    Blasi, Federico
    Croce, Francesca
    Seganfreddo, Francesca
    Refujiati, Taulant
    Marazzato, Jacopo
    De Ponti, Roberto
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G) : G48 - +
  • [38] Advanced echocardiographic assessment in outpatients with advanced heart failure undergoing periodical levosimendan infusion
    Morello, Matteo
    Miglierina, Emilio
    Golino, Michele
    Ceriani, Francesca
    Oliva, Carlo
    Blasi, Federico
    Croce, Francesca
    Seganfreddo, Francesca
    Refujiati, Taulant
    Marazzato, Jacopo
    De Ponti, Roberto
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [39] Hemodynamic evaluation of patients with advanced heart failure receiving ambulatory intermittent cycles of levosimendan as bridge to transplant
    Ponz De Antonio, I.
    De Juan Baguda, J.
    Rodriguez Chaverri, A.
    Moran Fernandez, L.
    Blazquez Bermejo, Z.
    Cosio Carmena, M. D. Garcia
    Ortiz Bautista, C.
    Hernandez, I.
    Escribano Subias, P.
    Munera Jimenez, C.
    Gutierrez Garcia, R.
    Salguero Bodes, R.
    Arribas Ynsaurriaga, F.
    Delgado Jimenez, J. F.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1391 - 1391
  • [40] Intermittent Levosimendan Infusions in Advanced Heart Failure: Favourable Effects on Left Ventricular Function, Neurohormonal Balance, and One-Year Survival
    Malfatto, Gabriella
    Della Rosa, Francesco
    Villani, Alessandra
    Rella, Valeria
    Branzi, Giovanna
    Facchini, Mario
    Parati, Gianfranco
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2012, 60 (05) : 450 - 455